Energenesis Biomedical CO.,LTD. (TPE:6657)
Taiwan · Delayed Price · Currency is TWD 44.40
+0.05 (0.11%)
Mar 24, 2026, 1:30 PM CST
TPE:6657 Market Cap
TPE:6657 has a market cap or net worth of 3.94 billion as of March 24, 2026. Its market cap has decreased by -36.73% in one year.
Market Cap
3.94B
Enterprise Value
3.11B
Revenue
7.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
44.40
Market Cap Chart
Since August 8, 2018, TPE:6657's market cap has increased from 1.02B to 3.94B, an increase of 284.79%. That is a compound annual growth rate of 19.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 3.93B | 3.14% |
| Dec 31, 2025 | 3.81B | -1.55% |
| Dec 31, 2024 | 3.87B | -15.67% |
| Dec 29, 2023 | 4.59B | 60.69% |
| Dec 30, 2022 | 2.86B | -4.64% |
| Dec 30, 2021 | 3.00B | 2.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OBI Pharma | 5.01B |
| Locus Cell | 4.96B |
| Medigen Biotechnology | 4.63B |
| BioGend Therapeutics | 4.22B |
| Formosa Pharmaceuticals | 3.93B |
| ACRO Biomedical | 3.78B |
| Genovate Biotechnology | 3.45B |
| Sagittarius Life Science | 3.40B |